Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson's disease treatment.
about
Engineering poly(lactic-co-glycolic acid) (PLGA) micro- and nano-carriers for Controlled Delivery of 17β-Estradiol.Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction.Overcoming blood brain barrier with a dual purpose Temozolomide loaded Lactoferrin nanoparticles for combating glioma (SERP-17-12433).MicroRNA-27b inhibition promotes Nrf2/ARE pathway activation and alleviates intracerebral hemorrhage-induced brain injury.Intranasal delivery of α-asarone to the brain with lactoferrin-modified mPEG-PLA nanoparticles prepared by premix membrane emulsification.Lactoferrin-modified rotigotine nanoparticles for enhanced nose-to-brain delivery: LESA-MS/MS-based drug biodistribution, pharmacodynamics, and neuroprotective effects.Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting.Current Trends in Biomaterial Utilization for Cardiopulmonary System Regeneration.Nanoparticle delivery of grape seed-derived proanthocyanidins to airway epithelial cells dampens oxidative stress and inflammation.Rasagiline-encapsulated chitosan-coated PLGA nanoparticles targeted to the brain in the treatment of parkinson's diseaseNose-to-brain delivery of temozolomide-loaded PLGA nanoparticles functionalized with anti-EPHA3 for glioblastoma targeting
P2860
Q39387324-4473D0B3-C9CC-4153-95E7-D3A6D1AF01EEQ41018640-355E7497-5BBC-4ACF-9613-6C7F08B7C66DQ41141280-01972799-3495-46EE-997D-134D42D30B52Q42378464-A6B5889D-8565-4719-AE62-A261B295D893Q47351572-F89D922A-1927-42CF-905F-45C0933B8FD6Q47825089-1A99C200-E953-4EC7-9F3D-7FB0C7493957Q49393483-6BD96207-A4B4-4CDD-B0CC-6F8456C26B60Q52654049-EDED1D7C-768F-4D26-BE70-9D651CB7E230Q54945960-0F1F6ADE-7A20-466F-B385-76761CC138A4Q55332967-5EADC4CB-C84C-464A-A1E7-C5FFCD45C896Q57369531-435DD852-27E1-4F50-9EFA-0CB82DCD606BQ58767702-9353601F-57A7-44F8-AA6D-0D1E24078A17
P2860
Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson's disease treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intranasal delivery of rotigot ...... Parkinson's disease treatment.
@en
Intranasal delivery of rotigot ...... Parkinson's disease treatment.
@nl
type
label
Intranasal delivery of rotigot ...... Parkinson's disease treatment.
@en
Intranasal delivery of rotigot ...... Parkinson's disease treatment.
@nl
prefLabel
Intranasal delivery of rotigot ...... Parkinson's disease treatment.
@en
Intranasal delivery of rotigot ...... Parkinson's disease treatment.
@nl
P2093
P2860
P356
P1476
Intranasal delivery of rotigot ...... Parkinson's disease treatment.
@en
P2093
Aiping Wang
Chenchen Bi
Hongjie Mu
Kaoxiang Sun
Wanhui Liu
Yongchao Chu
P2860
P304
P356
10.2147/IJN.S120939
P407
P577
2016-12-07T00:00:00Z